Send me a link:

*Text messaging rates may apply.

 Dow Up 0.13% Nasdaq Down 0.10%

More On TTH.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Transition Therapeutics Inc. (TTH.TO)

-Toronto
6.81 Down 0.02(0.29%) Jul 28
Prev Close:6.83
Open:6.83
Bid:5.56
Ask:7.00
1y Target Est:N/A
Beta:0.66
Earnings Date:Sep 8 - Sep 12 (Est.)
Day's Range:6.78 - 6.83
52wk Range:4.04 - 9.25
Volume:1,620
Avg Vol (3m):2,368
Market Cap:207.27M
P/E (ttm):N/A
EPS (ttm):-0.37
Div & Yield:0.06 (0.20%)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Headlines

» More Headlines for TTH.TO

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):29.20
Ex-Dividend Date:29-Dec-10

Analysts

Annual EPS Est (Jun-14) :-0.64
Quarterly EPS Est (Jun-14) :-0.30
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Transition Therapeutics Inc., a biopharmaceutical company, develops therapeutics for various disease indications primarily in Canada. Its lead CNS drug candidate includes ELND005, a Phase II clinical trial product for the treatment of Alzheimer... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback